Janux Therapeutics, Inc. (JANX)
16.39
-0.72
(-4.21%)
USD |
NASDAQ |
Dec 04, 16:00
16.40
+0.01
(+0.06%)
After-Hours: 20:00
Janux Therapeutics Market Cap: 985.82M for Dec. 4, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Stoke Therapeutics, Inc. | 1.774B |
| Merck & Co., Inc. | 250.26B |
| Editas Medicine, Inc. | 237.70M |
| Syndax Pharmaceuticals, Inc. | 1.717B |
| Entrada Therapeutics, Inc. | 389.07M |
Market Cap Related Metrics
| PS Ratio | 99.38 |
| PEG Ratio | -0.2304 |
| Price to Book Value | 1.009 |
| Price | 16.39 |
| Earnings Yield | -10.22% |
| PEGY Ratio | -0.2304 |